Correlation Between Dupont De and Molecular Pharmacology
Can any of the company-specific risk be diversified away by investing in both Dupont De and Molecular Pharmacology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Molecular Pharmacology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Molecular Pharmacology, you can compare the effects of market volatilities on Dupont De and Molecular Pharmacology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Molecular Pharmacology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Molecular Pharmacology.
Diversification Opportunities for Dupont De and Molecular Pharmacology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dupont and Molecular is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Molecular Pharmacology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Pharmacology and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Molecular Pharmacology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Pharmacology has no effect on the direction of Dupont De i.e., Dupont De and Molecular Pharmacology go up and down completely randomly.
Pair Corralation between Dupont De and Molecular Pharmacology
If you would invest 0.01 in Molecular Pharmacology on October 9, 2024 and sell it today you would earn a total of 0.00 from holding Molecular Pharmacology or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dupont De Nemours vs. Molecular Pharmacology
Performance |
Timeline |
Dupont De Nemours |
Molecular Pharmacology |
Dupont De and Molecular Pharmacology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dupont De and Molecular Pharmacology
The main advantage of trading using opposite Dupont De and Molecular Pharmacology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Molecular Pharmacology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Pharmacology will offset losses from the drop in Molecular Pharmacology's long position.Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
Molecular Pharmacology vs. Curative Biotechnology | Molecular Pharmacology vs. Vertex Pharmaceuticals | Molecular Pharmacology vs. BioNTech SE | Molecular Pharmacology vs. Moderna |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |